To include your compound in the COVID-19 Resource Center, submit it here.

CytRx preclinical data

In a mouse xenograft model of ovarian cancer, 24 mg/kg INNO-206 led to significantly

Read the full 142 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE